Oxford Genome Sciences said last week that UCB, a biopharmaceutical firm based in Belgium, has licensed its Oxford Genome Anatomy Project (OGAP) database — the first such deal for OGeS since it launched 18 months ago.

OGeS was founded by several members of Oxford GlycoSciences' proteomics team after Celltech acquired that firm in December 2003. OGeS CEO Christian Rohlff and several of his OGS colleagues acquired a suite of technology, data, and intellectual property that Celltech jettisoned at the time of the OGS acquisition [BioInform 11-24-03].

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.